Next generation gene editing - two decades after we learned how to read the human genome, we’re entering the era of gene writing enabled by CRISPR/Cas9.
We continue to push the boundaries of what’s possible with gene editing in the pursuit of new medicines.
We have a dedicated team called CRISPR-X that focuses on innovative research to develop next-generation editing and delivery modalities, such as all-RNA gene correction, whole gene insertion and non-viral delivery of DNA. These cutting-edge technologies could underlie the next wave of gene-editing therapies.
To learn more about the full range of investigational therapies we are developing, visit our pipeline page.
Are you ready to work at the cutting edge of gene editing? Learn more about opportunities to join our team.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.